INTERNATIONAL PATENT: CATALYM GMBH FILES APPLICATION FOR "ANTI-HGDF-15 ANTIBODY FOR USE IN THE TREATMENT OF CANCER IN A PATIENT IN COMBINATION WITH A CANCER ANTIGEN-TARGETED DRUG CONJUGATE THAT INDUCES CANCER CELL STRESS"

GENEVA, July 14 -- CATALYM GMBH (Am Klopferspitz 1982152 Planegg-Martinsried) filed a patent application (PCT/EP2025/050110) for "ANTI-HGDF-15 ANTIBODY FOR USE IN THE TREATMENT OF CANCER IN A PATIENT IN COMBINATION WITH A CANCER ANTIGEN-TARGETED DRUG CONJUGATE THAT INDUCES CANCER CELL STRESS" on Jan 03, 2025. With publication no. WO/2025/146488, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GENSSLER, Sabrina (CatalYm GmbHAm Klopferspitz 1982152 Martinsried), SCHUBERTH-WAGNER, Christine (CatalYm GmbHAm Klopferspitz 19821...